What is the EBMT
What is the EBMT?Related Meetings
MembershipRegistryWorking PartiesNurses GroupDirectoryTransplant GuidelinesCorporate Sponsorship

EBMT Centres interested in hosting a fellow*

*If your centre is a Higher Education Institution (HEI) and wishes to be considered as a potential host for a fellow please email us with your details and the name of a contact person. All HEIs are asked to provide details of their areas of speciality.

Further contact details for the centres listed below can be found on the EBMT Membership list.


Areas of Speciality (where defined)
Australia 
CIC 698
Sydney Children`s Hospital, Sydney
Contact Person: Tracey O'Brien
CIC 711
The Children's Hospital at Westmead, Sydney
Contact Person: Peter J. Shaw

1.Clinical BMT - paediatric Children’s Hospital (Prof Peter J. Shaw) and adult - Westmead Hospital . (Prof Ken Bradstock)

2.The joint BMT processing laboratory (Sydney Cellular Therapies Laboratory)

3.The Cellular Immunotherapy Unit (Prof David Gottlieb) in the Millennium Institute

4.The Centre of Clinical Research Excellence - Infection and Bioethics in Haematology Malignancies (Prof Tania Sorrell)

5.The Gene Therapy Programme (Ian Alexander)

6.The Oncology Research Unit (Prof Peter Gunning)

7.The Oncology Unit (Dr Luciano Dalla-Pozza)

Austria

 
CIC 227
Medizinische Universitaet Wien, Vienne
Contact Person: Hildegard Greinix
1.Acute and chronic graft-versus-host disease

2. Pathophysiology, treatment strategies, biomarkers

3. Extracorporeal photopheresis: mechanisms of action, clinical use in Phase I to III studies

4. Predictive markers for transplant outcome: HLA and non-HLA gene polymorphisms
France 
CIC 207
Hopital St. Louis, Paris
Contact Person: Gérard Socié
 
CIC 213
Hopital Saint Antoine, Paris
Contact Person: Norbert-Claude Gorin
 
CIC 230
Unité de transplantation et de thérapie cellulaire, Marseilles
Contact Person: Didier Blaise
 
CIC 252
Hôpital Henri Mondor, Creteil
Contact Person: Catherine Cordonnier

1.Allogeneic SCT

2.infectious complications

3.immunization after transplant

4.GVHD

CIC 666
Institut Gustave Roussy, Villejuif Val de Marne
Contact Person: Jean Henri Bourhis
 
CIC 671
Hopital E. Herriot, Lyon
Contact Person: Mauricette Michallet

1.Chronic leukaemias

2.Myeloma

3. MDS

4. Haematopoietic Stem Cell auto transplantations and allo transplantations

Germany 
CIC 295
Hannover Medical University, Hannover
Contact Person: Peter A. Horn
 
CIC 389
University of Leipzig, Leipzig
Contact Person: Dietger Niederwieser
 
CIC 524
University of Heidelberg, Heidelberg
Contact Person: Peter Dreger
 
CIC 590
Charité - Campus Benjamin Franklin, Berlin
Contact Person: Lutz Uharek
 
CIC 614
University Hospital Eppendorf Bone Marrow Transplantation Centre
Contact Person: Axel Zander
1. Gene therapy

2. Unrelated stem cell transplantation

3. Mesenchymal stem cells

4. Minimal residual disease
CIC 787
University Regensburg, Regensburg
Contact Person: Ernst Holler
 
Italy 
CIC 217
Ospedale San Martino, Genova
Contact Person: Andrea Bacigalupo
1.GvHD prophylaxis

2.Cord Blood Transplants

3.Unrelated transplants

4.Minimal Residual Disease
CIC 304
Ospedale di Careggi, Firenze
Contact Person: Riccardo Saccardi
 
CIC 307
Universita Cattolica S. Cuore, Rome
Contact Person: Simona Sica
 
CIC 616
University of Milano, Milano
Contact Person: Vittorio Montefusco
1.Lymphoma (auto and allo programs)

2.Minimal residual disease evaluation in B cell tumors

3.Haploidentical transplatation
CIC 692
Ospedale La Maddalena - Dpt. Oncologico, Palermo
Contact Person: Maurizio Musso
1.RICT in hematological malignancies
CIC 813
'Istituto Scientifico H.S. Raffaele, Milano
Contact Person: Fabio Ciceri
1.Allogeneic haploidentical SCT
The Netherlands 
CIC 237
'University Medical Center St. Radboud, Nijmegen
Contact Person: Theo M de Witte
 
CIC 239
University Medical Centre, Utrecht
Contact Person: Leo F.Verdonck
1.Allo-SCT,all clinical aspects,such as GVHD,GVL,immune recovery
Poland 
CIC 799
Medical University of Gdansk, Gdansk
Contact Person: Andrzej Hellmann
 
South Africa 
CIC 772
Constantiaberg Medi-Clinic, Cape Town
Contact Person: Peter Jacobs
 
Spain 
CIC 236
Hospital de la Princesa, Madrid
Contact Person: Adrian Alegre
 
CIC 727
Hospital Clínico, Salamanca
Contact Person: José A. Pérez-Simón
1.Cytogenetics / molecular biology in hematologic malignancies

2.EMR monitoring by flow cytometry

3.Allogeneic transplantation: clinical management both in vitro and in vivo

4.Biological research on GVHD models

5.New drug development in myeloma and AML
CIC 819
Hospital Gregorio Marañón, Madrid
Contact Person: Jose Diez-Martin
1. Allo-SCT
2.Graft Manipulation
3.Chimerism studies
Sweden 
CIC 740
University Hospital, Linköping
Contact Person: Kourosh Lotfi
 
United Kingdom 
CIC 205
Imperial College, London
Contact Person: Jane Apperley
 
CIC 244
Scottish National Volunteer Unrelated Donor Transplant Centre, Glasgow
Contact Person: Andrew Clark
1. Chronic Myeloid Leukaemia
2. Quiescent Stem cell populations in leukaemia
3. Graft versus host disease and chemokines
4. Fungal infection
CIC 216
Royal Free Hospital and School of Medicine, London
Contact Person: Stephen Mackinnon
 
CIC 501
Royal Liverpool University Hospital, Liverpool
Contact Person: Richard E Clark
1.BMT for chronic myeloid leukaemia
CIC 566
Addenbrookes Hospital, Cambridge
Contact Person: Charles Crawley
 
CIC 704
Southampton General Hospital
Contact Person: Kim Orchard
1. Novel Transplant conditioning
2. Targeted radiotherapy in transplant conditioning
3. Immune reconstitution
4. Immunotherapy in lymphoid malignancies
CIC 778
North Trent BMT Programme (Adults), Sheffiled
Contact Person: John Snowden
 
CIC 780
Christie NHS Trust Hospital, Manchester
Contact Person: E Liakopoulou
 

 

 

top

What is the EBMT? | Related Meetings | Membership | Registry | Working Parties
Nurses Group | Directory | Transplant Guidelines | Corporate Sponsorship

HOME | SITE MAP | RELATED LINKS | CONTACT US